{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:16:52Z","timestamp":1792001812826,"version":"4.4.0"},"reference-count":56,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n \n Several important vaccines, such as the\n Haemophilus influenzae<\/jats:italic>\n type b vaccine, rotavirus vaccine, pneumococcal conjugate vaccine, and influenza vaccine, have not been included in China\u2019s National Immunization Program (NIP) due to a prolonged absence of updates and limited resources. Public engagement could identify concerns that require attention and foster trust to ensure continuous support for immunization.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to identify public preferences for vaccine inclusion in the NIP and to determine the desired vaccine funding priorities in the Chinese population.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A dual-response discrete choice experiment was utilized to estimate the relative importance of 6 attributes, including incidence of vaccine-preventable diseases, mortality of vaccine-preventable diseases, vaccine effectiveness, vaccine cost, vaccinated group, and vaccine coverage. Participants were recruited through the Wenjuanxing platform using a census-based quota sample of the nationwide population aged 18 years and older. A mixed logit model was used to estimate the coefficient of attribute preferences and predict the selection probability. Subgroups and interaction effects were analyzed to examine the heterogeneity in preferences.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In total, 1258 participants completed the survey, of which 880 were involved in the main analysis and 1166 in the sensitivity analysis. The relative importance and model estimates of 2 attributes, vaccine cost and vaccination group, varied between the unforced- and forced-choice settings. All 6 vaccine attributes significantly influenced the preferences for vaccine inclusion, with vaccine effectiveness and coverage as the most important factors, followed by the vaccinated group and mortality of vaccine-preventable diseases in the unforced-choice settings. The top vaccines recommended for China\u2019s NIP included the varicella vaccine,\n Haemophilus influenzae<\/jats:italic>\n type b vaccine, enterovirus 71 vaccine, and influenza vaccine for preschoolers and school-aged children. The current analysis also revealed distinct preference patterns among different subgroups, such as gender, age, education, and income. The interaction analysis indicated that the region and health status of participants contribute to preference heterogeneity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Public preferences for including vaccines in the NIP were primarily influenced by vaccine effectiveness and coverage. The varicella vaccine should be prioritized for inclusion in the NIP. The public preferences could provide valuable insights when incorporating new vaccines in the NIP.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/57798","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:56:26Z","timestamp":1732600586000},"page":"e57798-e57798","source":"Crossref","is-referenced-by-count":8,"title":["Public Preference and Priorities for Including Vaccines in China\u2019s National Immunization Program: Discrete Choice Experiment"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7987-0217","authenticated-orcid":false,"given":"Lingli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-8061","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2101-1487","authenticated-orcid":false,"given":"Jiali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7962-5493","authenticated-orcid":false,"given":"Xiaoye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0331-2533","authenticated-orcid":false,"given":"Yuyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"R1","unstructured":"Vaccines and immunization. World Health Organization. URL: https:\/\/www.who.int\/health-topics\/vaccines-and-immunization [Accessed 30-01-2024]"},{"key":"R2","unstructured":"Immunization agenda 2030. World Health Organization. URL: https:\/\/www.who.int\/publications\/m\/item\/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind [Accessed 16-01-2024]"},{"issue":"12","key":"R3","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1016\/S2468-2667(22)00171-2","article-title":"Developing an effective and sustainable national immunisation programme in China: issues and challenges","volume":"7","author":"Chen","journal-title":"Lancet Public Health"},{"key":"R4","unstructured":"WHO recommendations for routine immunization. World Health Organization. URL: https:\/\/www.who.int\/publications\/m\/item\/table-1-who-recommendations-for-routine-immunization [Accessed 12-01-2024]"},{"issue":"12","key":"R5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.46005","article-title":"Coverage and equity of childhood vaccines in China","volume":"5","author":"Zhang","journal-title":"JAMA Netw Open"},{"key":"R6","unstructured":"Principles and considerations for adding a vaccine to a national immunization program: from decision to implementation and monitoring. World Health Organization. URL: https:\/\/www.who.int\/publications-detail-redirect\/9789241506892 [Accessed 17-08-2023]"},{"issue":"4","key":"R7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1382","article-title":"Rotavirus gastroenteritis infection among children vaccinated and unvaccinated with rotavirus vaccine in southern China: a population-based assessment","volume":"1","author":"Fu","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-020-01545-6","article-title":"Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis","volume":"18","author":"Yang","journal-title":"BMC Med"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12916-021-02049-7","article-title":"National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis","volume":"19","author":"Zhang","journal-title":"BMC Med"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13056-5","article-title":"Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model","volume":"22","author":"Zhou","journal-title":"BMC Public Health"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100430","article-title":"National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010\u201317","volume":"22","author":"Lai","journal-title":"Lancet Reg Health West Pac"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100639","article-title":"National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis","volume":"32","author":"Feng","journal-title":"Lancet Reg Health West Pac"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100666","article-title":"Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis","volume":"32","author":"Lai","journal-title":"Lancet Reg Health West Pac"},{"issue":"12","key":"R14","doi-asserted-by":"publisher","first-page":"e1016","DOI":"10.1016\/S2468-2667(23)00248-7","article-title":"Adding new childhood vaccines to China\u2019s National Immunization Program: evidence, benefits, and priorities","volume":"8","author":"Zhang","journal-title":"Lancet Public Health"},{"issue":"7","key":"R15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071010","article-title":"Prioritization of vaccines for inclusion into China\u2019s expanded program on immunization: evidence from experts\u2019 knowledge and opinions","volume":"10","author":"Ma","journal-title":"Vaccines"},{"issue":"Suppl 2","key":"R16","doi-asserted-by":"publisher","first-page":"ii77","DOI":"10.1093\/heapol\/czs038","article-title":"The role of publics in the introduction of new vaccines","volume":"27 Suppl 2","author":"Paterson","journal-title":"Health Policy Plan"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","article-title":"Discrete choice experiments in health economics: past, present and future","volume":"37","author":"Soekhai","journal-title":"Pharmacoeconomics"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.03.025","article-title":"Quantifying the public\u2019s view on social value judgments in vaccine decision-making: a discrete choice experiment","volume":"228","author":"Luyten","journal-title":"Soc Sci Med"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.114991","article-title":"Social preferences for adopting new vaccines in the national immunization program: a discrete choice experiment","volume":"303","author":"Luyten","journal-title":"Soc Sci Med"},{"issue":"4","key":"R20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","volume":"14","author":"Bridges","journal-title":"Value Health"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force","volume":"16","author":"Reed Johnson","journal-title":"Value Health"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force","volume":"19","author":"Hauber","journal-title":"Value Health"},{"issue":"14","key":"R23","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.vaccine.2021.02.059","article-title":"National decision-making for the introduction of new vaccines: a systematic review, 2010-2020","volume":"39","author":"Donadel","journal-title":"Vaccine"},{"issue":"4","key":"R24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11002-006-7943-8","article-title":"The no-choice option and dual response choice designs","volume":"17","author":"Brazell","journal-title":"Market Lett"},{"issue":"5","key":"R25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample size requirements for discrete-choice experiments in healthcare: a practical guide","volume":"8","author":"de Bekker-Grob","journal-title":"Patient"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chb.2014.03.062","article-title":"Online sexual activity in Mainland China: relationship to sexual sensation seeking and sociosexuality","volume":"36","author":"Zheng","journal-title":"Comput Hum Behav"},{"key":"R27","unstructured":"Wenjuanxing. URL: https:\/\/www.wjx.cn\/ [Accessed 31-10-2024]"},{"issue":"7","key":"R28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40273-017-0506-4","article-title":"Discrete choice experiments: a guide to model specification, estimation and software","volume":"35","author":"Lancsar","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"R29","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.socscimed.2006.12.007","article-title":"Several methods to investigate relative attribute impact in stated preference experiments","volume":"64","author":"Lancsar","journal-title":"Soc Sci Med"},{"issue":"7","key":"R30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011405","article-title":"Vaccine pricing strategies in China","volume":"8","author":"Zhang","journal-title":"BMJ Glob Health"},{"key":"R31","unstructured":"Notice on the announcement of the supplementary products (the seventh batch) and the updated list of non-immunization program vaccines used in Guangdong province for the year 2023. Guang Dong Medicine Exchange. URL: https:\/\/www.gdmede.com.cn\/announcement\/announcement\/detail?id=1722537139872206848 [Accessed 24-11-2023]"},{"issue":"4","key":"R32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.19914\/j.cjvi.2020.04.011","article-title":"Epidemiological characteristics of varicella in China, 2016-2019","volume":"26","author":"Dong","journal-title":"Chin J Vaccine Immuniz"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06217-1","article-title":"Two-dose varicella vaccine effectiveness in China: a meta-analysis and evidence quality assessment","volume":"21","author":"Zhang","journal-title":"BMC Infect Dis"},{"issue":"8","key":"R34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1017\/S0950268812000957","article-title":"Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials","volume":"140","author":"Griffiths","journal-title":"Epidemiol Infect"},{"issue":"2","key":"R35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3760\/cma.j.issn.0254-6450.2019.02.005","article-title":"Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017 [Article in Chinese]","volume":"40","author":"Zhang","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"9","key":"R36","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/cid\/ciz1114","article-title":"Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6\u201371 months in a phase IV study","volume":"71","author":"Guan","journal-title":"Clin Infect Dis"},{"issue":"4","key":"R37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.7423","article-title":"Estimated incidence of seasonal influenza in China from 2010 to 2020 using a multiplier model","volume":"5","author":"Wang","journal-title":"JAMA Netw Open"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82161-z","article-title":"Influenza-associated disease burden in mainland China: a systematic review and meta-analysis","volume":"11","author":"Li","journal-title":"Sci Rep"},{"issue":"2","key":"R39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020079","article-title":"Influenza vaccine effectiveness in Mainland China: a systematic review and meta-analysis","volume":"9","author":"Yang","journal-title":"Vaccines"},{"issue":"48","key":"R40","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1016\/j.vaccine.2018.10.045","article-title":"Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis","volume":"36","author":"Wang","journal-title":"Vaccine"},{"issue":"33","key":"R41","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1016\/j.vaccine.2021.06.075","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study","volume":"39","author":"Zhang","journal-title":"Vaccine"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016","volume":"2","author":"Zheng","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12879-017-2592-5","article-title":"Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China","volume":"17","author":"Mo","journal-title":"BMC Infect Dis"},{"issue":"5","key":"R44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.19914\/j.CJVI.2021101","article-title":"Human papillomavirus vaccine coverage among the 9-45-year-old female population of China in 2018-2020","volume":"27","author":"Song","journal-title":"Chin J Vaccine Immuniz"},{"issue":"2","key":"R45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3760\/cma.j.issn.0253-9624.2020.02.013","article-title":"Analysis of epidemiological characteristics of report cases of rotavirus diarrhea in children under 5 years old in China, 2005-2018","volume":"54","author":"Luo","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"1","key":"R46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12985-022-01898-9","article-title":"Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study","volume":"19","author":"Du","journal-title":"Virol J"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113461","article-title":"Effectiveness of pentavalent rotavirus vaccine in Shanghai, China: a test-negative design study","volume":"259","author":"Ma","journal-title":"J Pediatr"},{"issue":"11","key":"R48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111805","article-title":"The effect of including an opt-out option in discrete choice experiments","volume":"9","author":"Veldwijk","journal-title":"PLoS One"},{"issue":"1","key":"R49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-018-0324-6","article-title":"Including opt-out options in discrete choice experiments: issues to consider","volume":"12","author":"Campbell","journal-title":"Patient"},{"issue":"1","key":"R50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40273-022-01198-8","article-title":"Patient preferences in targeted pharmacotherapy for cancers: a systematic review of discrete choice experiments","volume":"41","author":"Jiang","journal-title":"Pharmacoeconomics"},{"issue":"30","key":"R51","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1016\/j.vaccine.2019.05.072","article-title":"The relative effects of determinants on Chinese adults\u2019 decision for influenza vaccination choice: what is the effect of priming?","volume":"37","author":"Liao","journal-title":"Vaccine"},{"issue":"1","key":"R52","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08844-w","article-title":"Preferential differences in vaccination decision-making for oneself or one\u2019s child in The Netherlands: a discrete choice experiment","volume":"20","author":"Hoogink","journal-title":"BMC Public Health"},{"issue":"1","key":"R53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40249-023-01142-8","article-title":"Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China","volume":"12","author":"Lyu","journal-title":"Infect Dis Poverty"},{"issue":"8","key":"R54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The effectiveness of varicella vaccine in China","volume":"29","author":"Fu","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"R55","doi-asserted-by":"publisher","first-page":"2194190","DOI":"10.1080\/21645515.2023.2194190","article-title":"Driving more WHO-recommended vaccines in the National Immunization Program: issues and challenges in China","volume":"19","author":"Dai","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"R56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/jssam\/smt008","article-title":"Summary report of the AAPOR task force on non-probability sampling","volume":"1","author":"Baker","journal-title":"J Surv Stat Methodol"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publichealth.jmir.org\/2024\/1\/e57798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:48:51Z","timestamp":1782841731000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2024\/1\/e57798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":56,"URL":"https:\/\/doi.org\/10.2196\/57798","relation":{},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"article-number":"v10i12e57798"}}